Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04859725

HyperSpectral Imaging in Low Grade Glioma

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2025-01-08

10

Participants Needed

1

Research Sites

213 weeks

Total Duration

On this page

Sponsors

U

Universitaire Ziekenhuizen KU Leuven

Lead Sponsor

I

Imec

Collaborating Sponsor

AI-Summary

What this Trial Is About

Low grade glioma (LGG) is a slowly evolving, highly invasive intrinsic brain tumor displaying only subtle tissue differences with the normal surrounding brain, hampering the attempts to visually discriminate tumor from normal brain, especially at the border interface. This makes anatomical borders hard to define during early maximal resection, which is the initial treatment strategy. Therefore, innovative, robust and easy-to-use real-time strategies for intra-operative detection and discrimination of (residual) LGG tumor tissue would strongly influence on-site, surgical decision making, enabling a maximal extent of resection. To validate this approach hyperspectral imaging (HSI) - using a SnapScan HSI-Camera (IMEC), stably mounted on an OPMI Pentero 900 microscope (Zeiss) - will be used to generate spectral imaging data patterns that discriminate in vivo low grade glioma tissue from normal brain both on the cortical and subcortical level.

CONDITIONS

Official Title

HyperSpectral Imaging in Low Grade Glioma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 63 18 years
  • Radiologically suspected low grade glioma (newly diagnosed or recurrent)
  • Scheduled for tumor resection at UZ Leuven
  • Signed informed consent document prior to resection
Not Eligible

You will not qualify if you...

  • Children with age < 18 years
  • If final pathology shows a diagnosis other than low grade glioma, data will be excluded from analysis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UZ Leuven

Leuven, Vlaams-Brabant, Belgium, 3000

Actively Recruiting

Loading map...

Research Team

S

Steven De Vleeschouwer, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DEVICE_FEASIBILITY

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here